Arcutis Biotherapeutics, Inc. (ARQT) Now Trades Above Golden Cross: Time to Buy?

Technical Analysis - ARQT's 50-day simple moving average broke above its 200-day moving average, forming a "golden cross," a bullish technical indicator [1] - The golden cross consists of three stages: price bottoming out, short-term moving average crossing above long-term moving average, and maintaining upward momentum [1] - ARQT has gained 34.5% over the past four weeks [1] Earnings Outlook - No earnings estimate cuts for the current quarter, with 3 upward revisions in the past 60 days [2] - Zacks Consensus Estimate has increased, indicating a positive earnings outlook [2] Investment Potential - ARQT currently holds a 2 (Buy) rating on the Zacks Rank, suggesting potential for a breakout [1] - The combination of technical indicators and positive earnings revisions strengthens the bullish case for ARQT [1][2]